Industry: Healthcare
Published Date: March-2025
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 250
Report ID: PMRREP33256
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand-side Trends
1.3. Supply-side Trends
1.4. Technology Roadmap Analysis
1.5. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Background
3.1. Market Dynamics
3.1.1. Drivers
3.1.2. Restraints
3.1.3. Opportunity
3.1.4. Trends
3.2. Scenario Forecast
3.2.1. Demand in Optimistic Scenario
3.2.2. Demand in Likely Scenario
3.2.3. Demand in Conservative Scenario
3.3. Opportunity Map Analysis
3.4. Product Life Cycle Analysis
3.5. Investment Feasibility Matrix
3.6. PESTLE and Porter’s Analysis
3.7. Regulatory Landscape
3.7.1. By Key Regions
3.7.2. By Key Countries
3.8. Regional Parent Market Outlook
4. Global Drug of Abuse Testing Services Market Analysis, 2019 - 2032
4.1. Historical Market Size Value (US$ Mn) Analysis, 2019-2023
4.2. Current and Future Market Size Value (US$ Mn) Projections, 2024-2032
4.2.1. Y-o-Y Growth Trend Analysis
4.2.2. Absolute $ Opportunity Analysis
5. Global Drug of Abuse Testing Services Market Analysis, 2019 - 2032, By Drug Type
5.1. Introduction / Key Findings
5.2. Historical Market Size Value (US$ Mn) Analysis By Drug Type, 2019-2023
5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Drug Type, 2024-2032
5.3.1. Alcohol
5.3.2. Cannabis/Marijuana
5.3.3. Cocaine
5.3.4. Opioids
5.3.5. Amphetamine & Methamphetamine
5.3.6. LSD
5.3.7. Other Drug Types
5.4. Y-o-Y Growth Trend Analysis By Drug Type, 2019-2023
5.5. Absolute $ Opportunity Analysis By Drug Type, 2024-2032
6. Global Drug of Abuse Testing Services Market Analysis, 2019 - 2032, By Region
6.1. Introduction
6.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2019-2023
6.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2024-2032
6.3.1. North America
6.3.2. Latin America
6.3.3. Europe
6.3.4. Asia Pacific
6.3.5. Middle East and Africa
6.4. Market Attractiveness Analysis By Region
7. North America Drug of Abuse Testing Services Market Analysis, 2019 - 2032, By Country
7.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
7.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
7.2.1. By Country
7.2.1.1. U.S.
7.2.1.2. Canada
7.2.2. By Drug Type
7.3. Market Attractiveness Analysis
7.3.1. By Country
7.3.2. By Drug Type
7.4. Key Takeaways
8. Latin America Drug of Abuse Testing Services Market Analysis, 2019 - 2032, By Country
8.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
8.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
8.2.1. By Country
8.2.1.1. Brazil
8.2.1.2. Mexico
8.2.1.3. Rest of Latin America
8.2.2. By Drug Type
8.3. Market Attractiveness Analysis
8.3.1. By Country
8.3.2. By Drug Type
8.4. Key Takeaways
9. Europe Drug of Abuse Testing Services Market Analysis, 2019 - 2032, By Country
9.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
9.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
9.2.1. By Country
9.2.1.1. Germany
9.2.1.2. U.K.
9.2.1.3. France
9.2.1.4. Spain
9.2.1.5. Italy
9.2.1.6. Russia
9.2.1.7. Rest of Europe
9.2.2. By Drug Type
9.3. Market Attractiveness Analysis
9.3.1. By Country
9.3.2. By Drug Type
9.4. Key Takeaways
10. Asia Pacific Drug of Abuse Testing Services Market Analysis, 2019 - 2032, By Country
10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
10.2.1. By Country
10.2.1.1. China
10.2.1.2. Japan
10.2.1.3. India
10.2.1.4. South Korea
10.2.1.5. Australia
10.2.1.6. Rest of APAC
10.2.2. By Drug Type
10.3. Market Attractiveness Analysis
10.3.1. By Country
10.3.2. By Drug Type
10.4. Key Takeaways
11. Middle East and Africa Drug of Abuse Testing Services Market Analysis, 2019 - 2032, By Country
11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2024-2032
11.2.1. By Country
11.2.1.1. South Africa
11.2.1.2. Saudi Arabia
11.2.1.3. UAE
11.2.1.4. Israel
11.2.1.5. Rest of MEA
11.2.2. By Drug Type
11.3. Market Attractiveness Analysis
11.3.1. By Country
11.3.2. By Drug Type
11.4. Key Takeaways
12. Key Countries Drug of Abuse Testing Services Market Analysis
12.1. U.S.
12.1.1. Pricing Analysis
12.1.2. Market Share Analysis, 2023
12.1.2.1. By Drug Type
12.2. Canada
12.2.1. Pricing Analysis
12.2.2. Market Share Analysis, 2023
12.2.2.1. By Drug Type
12.3. Brazil
12.3.1. Pricing Analysis
12.3.2. Market Share Analysis, 2023
12.3.2.1. By Drug Type
12.4. Mexico
12.4.1. Pricing Analysis
12.4.2. Market Share Analysis, 2023
12.4.2.1. By Drug Type
12.5. Germany
12.5.1. Pricing Analysis
12.5.2. Market Share Analysis, 2023
12.5.2.1. By Drug Type
12.6. U.K.
12.6.1. Pricing Analysis
12.6.2. Market Share Analysis, 2023
12.6.2.1. By Drug Type
12.7. France
12.7.1. Pricing Analysis
12.7.2. Market Share Analysis, 2023
12.7.2.1. By Drug Type
12.8. Spain
12.8.1. Pricing Analysis
12.8.2. Market Share Analysis, 2023
12.8.2.1. By Drug Type
12.9. Italy
12.9.1. Pricing Analysis
12.9.2. Market Share Analysis, 2023
12.9.2.1. By Drug Type
12.10. Russia
12.10.1. Pricing Analysis
12.10.2. Market Share Analysis, 2023
12.10.2.1. By Drug Type
12.11. China
12.11.1. Pricing Analysis
12.11.2. Market Share Analysis, 2023
12.11.2.1. By Drug Type
12.12. Japan
12.12.1. Pricing Analysis
12.12.2. Market Share Analysis, 2023
12.12.2.1. By Drug Type
12.13. India
12.13.1. Pricing Analysis
12.13.2. Market Share Analysis, 2023
12.13.2.1. By Drug Type
12.14. South Korea
12.14.1. Pricing Analysis
12.14.2. Market Share Analysis, 2023
12.14.2.1. By Drug Type
12.15. Australia
12.15.1. Pricing Analysis
12.15.2. Market Share Analysis, 2023
12.15.2.1. By Drug Type
12.16. South Africa
12.16.1. Pricing Analysis
12.16.2. Market Share Analysis, 2023
12.16.2.1. By Drug Type
12.17. Saudi Arabia
12.17.1. Pricing Analysis
12.17.2. Market Share Analysis, 2023
12.17.2.1. By Drug Type
12.18. UAE
12.18.1. Pricing Analysis
12.18.2. Market Share Analysis, 2023
12.18.2.1. By Drug Type
12.19. Israel
12.19.1. Pricing Analysis
12.19.2. Market Share Analysis, 2023
12.19.2.1. By Drug Type
13. Market Structure Analysis
13.1. Competition Dashboard
13.2. Competition Benchmarking
13.3. Market Share Analysis of Top Players
13.3.1. By Regional
13.3.2. By Drug Type
14. Competition Analysis
14.1. Competition Deep Dive
14.1.1. Quest Diagnostics, Inc.
14.1.1.1. Overview
14.1.1.2. Product Portfolio
14.1.1.3. Profitability by Market Segments
14.1.1.4. Sales Footprint
14.1.1.5. Strategy Overview
14.1.1.5.1. Marketing Strategy
14.1.2. Abbott Laboratories
14.1.2.1. Overview
14.1.2.2. Product Portfolio
14.1.2.3. Profitability by Market Segments
14.1.2.4. Sales Footprint
14.1.2.5. Strategy Overview
14.1.2.5.1. Marketing Strategy
14.1.3. Clinical Reference Laboratory, Inc.
14.1.3.1. Overview
14.1.3.2. Product Portfolio
14.1.3.3. Profitability by Market Segments
14.1.3.4. Sales Footprint
14.1.3.5. Strategy Overview
14.1.3.5.1. Marketing Strategy
14.1.4. Laboratory Corporation of America Holdings
14.1.4.1. Overview
14.1.4.2. Product Portfolio
14.1.4.3. Profitability by Market Segments
14.1.4.4. Sales Footprint
14.1.4.5. Strategy Overview
14.1.4.5.1. Marketing Strategy
14.1.5. Cordant Health Solutions
14.1.5.1. Overview
14.1.5.2. Product Portfolio
14.1.5.3. Profitability by Market Segments
14.1.5.4. Sales Footprint
14.1.5.5. Strategy Overview
14.1.5.5.1. Marketing Strategy
14.1.6. Legacy Medical Services, LLC.
14.1.6.1. Overview
14.1.6.2. Product Portfolio
14.1.6.3. Profitability by Market Segments
14.1.6.4. Sales Footprint
14.1.6.5. Strategy Overview
14.1.6.5.1. Marketing Strategy
14.1.7. DrugScan
14.1.7.1. Overview
14.1.7.2. Product Portfolio
14.1.7.3. Profitability by Market Segments
14.1.7.4. Sales Footprint
14.1.7.5. Strategy Overview
14.1.7.5.1. Marketing Strategy
14.1.8. Omega Laboratories, Inc.
14.1.8.1. Overview
14.1.8.2. Product Portfolio
14.1.8.3. Profitability by Market Segments
14.1.8.4. Sales Footprint
14.1.8.5. Strategy Overview
14.1.8.5.1. Marketing Strategy
14.1.9. Psychemedics Corporation
14.1.9.1. Overview
14.1.9.2. Product Portfolio
14.1.9.3. Profitability by Market Segments
14.1.9.4. Sales Footprint
14.1.9.5. Strategy Overview
14.1.9.5.1. Marketing Strategy
14.1.10. Mayo Clinic Laboratories
14.1.10.1. Overview
14.1.10.2. Product Portfolio
14.1.10.3. Profitability by Market Segments
14.1.10.4. Sales Footprint
14.1.10.5. Strategy Overview
14.1.10.5.1. Marketing Strategy
15. Assumptions & Acronyms Used
16. Research Methodology
